Molten Ventures released its FY23 trading update (to end-March 2023), with its NAV per share down c 17% in FY23 to c 775p. That said, it...

This is the April edition of Edison Group’s Insight. They open with a strategy piece by Alastair George, who believes that the recovery...

Nano Dimension's FY22 results show that its ‘buy-and-build’ strategy has delivered a quadrupling of revenues during the year. The pace of...

Simon Gergel at Allianz Global Investors has managed The Merchants Trust PLC(MRCH),  a large British investment trust dedicated to...

Target Healthcare REIT Ltd (THRL)'s decision to rebase the quarterly DPS targeted for H223 (-17% to 1.4p per quarter) established full...

Alkane Resources Ltd continues to increase its production guidance, indicating confidence in a strong close to FY23, from 62,000–70,000oz...

Wheaton Precious Metals (WPM’s) Q123 results are scheduled for 4 May. Ahead of their release, Edison Group has refined their forecasts to...

With Q423 trading slightly better than expected, discoverIE Group plc is on track to deliver FY23 underlying earnings ahead of board...

Esker Inc reported 17% y-o-y revenue growth for Q123, with 21% y-o-y growth in SaaS revenue (83% of group revenue) on an organic constant...

Basilea Pharmaceutica has announced that there will be a minor delay in the timing of its new drug application (NDA) for Zevtera...